COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Acute pulmonary embolism: a review

Y Freund, F Cohen-Aubart, B Bloom - Jama, 2022 - jamanetwork.com
Importance Pulmonary embolism (PE) is characterized by occlusion of blood flow in a
pulmonary artery, typically due to a thrombus that travels from a vein in a lower limb. The …

Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

GD Barnes, A Burnett, A Allen, M Blumenstein… - Journal of thrombosis …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases,
result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic …

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …

SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial

AK Sista, JM Horowitz, VF Tapson, M Rosenberg… - Cardiovascular …, 2021 - jacc.org
Objectives This study sought to prospectively evaluate the safety and efficacy of the Indigo
aspiration system in submassive acute pulmonary embolism (PE). Background PE treatment …

A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study

T Tu, C Toma, VF Tapson, C Adams, WA Jaber… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: The aim of this study was to evaluate the safety and effectiveness of
percutaneous mechanical thrombectomy using the FlowTriever System (Inari Medical, Irvine …

Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report

C Kearon, EA Akl, J Ornelas, A Blaivas, D Jimenez… - Chest, 2016 - Elsevier
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

Therapeutic strategies for thrombosis: new targets and approaches

N Mackman, W Bergmeier, GA Stouffer… - Nature reviews Drug …, 2020 - nature.com
Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …